Table 2.
Clinicopathological characteristics of the SGC group (group A) and group with a diagnosis other than SGC (group B)
| Group A (n = 22) | Group B (n = 5) | p value | |
|---|---|---|---|
| Age, years | 78.0±7.5 | 70.6±19.8 | 0.07 |
| Sex | M: 7, F: 15 | M: 2, F: 3 | 0.73 |
| Site | 0.07 | ||
| Lower | 7 | 1 | |
| Upper | 14 | 2 | |
| Lower and upper | 1 | 2 | |
| T category | 0.78 | ||
| T1 | 16 | 4 | |
| T2 | 4 | 1 | |
| T3 | 2 | 0 | |
| Type | 0.06 | ||
| Nodule | 20 | 3 | |
| Diffuse | 2 | 2 | |
| Pagetoid spread | 0.09 | ||
| Presence | 5 | 3 | |
| Absence | 17 | 2 | |
| Time from symptom onset to visit our hospital, months | 4.3±3.9 | 5.2±3.4 | 0.33 |
| Initial diagnosis at another hospital | 0.56 | ||
| Benign disease | 12 | 2 | |
| Malignant tumor | 10 | 3 | |
| Postoperative follow-up period | 13.8±11.6 | 19.6±14.7 | 0.17 |
| Postoperative local recurrence or metastasis (+) | 3 | 1 | 0.71 |
M, male; F, female.